Skip to main content

Table 3 Patient factors associated with permanently switching to oral therapy on follow-up questionnaire

From: Oral vitamin B12therapy in the primary care setting: a qualitative and quantitative study of patient perspectives

 

No. (%) of subjects

Unadjusted

Adjusted*

Patient factor

Choosing oral therapy n = 39

Choosing injection therapy n = 13

OR (95% CI)

p-value

OR (95% CI)

p-value

Perceived disadvantages of injections

      

   Frequent visits to see MD/nurse

   Agree

27 (96)

1 (4)

27.00

<0.001

35.41

0.005

   Disagree

12 (50)

12 (50)

(3.14–231.87)

 

(2.90–432.70)

 

   Travel/parking costs

   Agree

23 (92)

2 (8)

7.91

0.016

8.66

0.036

   Disagree

16 (59)

11 (41)

(1.54–40.60)

 

(1.15–65.30)

 
  1. * Adjusted for patient factors at least weakly associated (i.e., p < 0.20) with permanently switching to oral B12 therapy in bivariate analyses: perceived disadvantages of injections (frequent visits to see MD/nurse, travel/parking costs), perceived disadvantage of pills (take too many pills already)
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us